Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Methods of inhibiting IL-2 production by T cells by administering 7C10 and 16C10 CD80-specific antibodies










Image Number 12 for United States Patent #7491393.

The present invention relates to the identification of antibodies which are specific to human B7.1 antigen (CD80) and which are capable of inhibiting the binding of B7.1 to a CD28 receptor and which are not capable of inhibiting the binding of B7.1 to a CTLA-4 receptor. Two of these antibodies, 16C10 and 7C10, significantly inhibit the production of IL-2, in spite of the existence of a second activating ligand B7.2 (CD86). Blocking of the primary activation signal between CD28 and B7.1 (CD80) with these antibodies while allowing the unimpaired or coincident interaction of CTLA-4 and B7.1 and/or B7.2 represents a combined antagonistic effect on positive co-stimulation with an agonistic effect on negative signalling. These antibodies may be used as specific immunosuppressants, e.g., for the treatment of autoimmune diseases and to prevent organ transplant rejection.








 
 
  Recently Added Patents
Optical article comprising a temporary anti-fogging coating with improved durability
Single well reservoir characterization apparatus and methods
Integrated multi-sat LNB and frequency translation module
Methods for predicting cardiac toxicity
Method for inhibiting thermal run-away
Low latency interrupt collector
Method for producing (meth)acrylic anhydride, method for storing (meth)acrylic anhydride, and method for producing (meth)acrylate
  Randomly Featured Patents
Method for reducing dark current
Electronic cash register
Glove
Image forming apparatus
Reel comprising reel halves
Solar heat absorber plate
Drum head tensioning device
Solid state lighting system
Temperature indicating strip
Brake unit having a nonmetallic brake disc of ceramic and a hub of a different material